Launched in the U.S. in 2023, NuvoAir is an integrated specialty care platform transforming how complex cardiopulmonary patients are treated. We focus on preventing and managing exacerbations, major drivers of healthcare costs, while providing ongoing, high-quality care. Our platform supports physicians by preserving their autonomy, improving patient outcomes, and unlocking new revenue opportunities. Through partnerships with health plans, risk-bearing groups, and forward-thinking cardiologists and pulmonologists, we are redefining care for people with serious heart and lung conditions. To discover more about how NuvoAir is advancing high-value care in the cardiopulmonary space and to explore NuvoAir's extensive body of clinical evidence, visit nuvoair.com.
